Next Article in Journal
Bacterial Colonization in Patients with Chronic Lymphocytic Leukemia and Factors Associated with Infections and Colonization
Next Article in Special Issue
Fractional Excretion of Phosphate (FeP) Is Associated with End-Stage Renal Disease Patients with CKD 3b and 5
Previous Article in Journal
Effects of a High Fat Meal Associated with Water, Juice, or Champagne Consumption on Endothelial Function and Markers of Oxidative Stress and Inflammation in Young, Healthy Subjects
Previous Article in Special Issue
Serologic and Histologic Predictors of Long-Term Renal Outcome in Biopsy-Confirmed IgA Nephropathy (Haas Classification): An Observational Study
Open AccessReview

Levamisole in Children with Idiopathic Nephrotic Syndrome: Clinical Efficacy and Pathophysiological Aspects

1
Department of Pediatrics, University Hamburg-Eppendorf, 20246 Hamburg, Germany
2
Department of Nephrology, Yonsei University Wonju College of Medicine, Wonju, Kangwon 26426, Korea
3
Department of Pediatrics, Asklepios Klink Nord-Heidberg, 22417 Hamburg, Germany
4
Department of Internal Medicine IV (Nephrology and Hypertension), Medical University Innsbruck, Innsbruck 6020, Austria
5
Department of Pediatric Nephrology, Chungnam National University Hospital, Daejeon 35015, Korea
6
Department of Pediatrics, Yonsei University College of Medicine, Seoul 03722, Korea
7
Division of Pediatric Nephrology, Severance Children’s Hospital, Seoul 03722, Korea
8
Institute of Kidney Disease Research, Yonsei University College of Medicine, Seoul 03722, Korea
*
Author to whom correspondence should be addressed.
These authors contributed equally to this work.
J. Clin. Med. 2019, 8(6), 860; https://doi.org/10.3390/jcm8060860
Received: 30 May 2019 / Revised: 11 June 2019 / Accepted: 12 June 2019 / Published: 16 June 2019
Steroid sensitive nephrotic syndrome is one of the most common pediatric glomerular diseases. Unfortunately, it follows a relapsing and remitting course in the majority of cases, with 50% of all cases relapsing once or even more often. Most children with idiopathic nephrotic syndrome respond initially to steroid therapy, nevertheless repeated courses for patients with relapses induce significant steroid toxicity. Patients with frequent relapses or steroid dependency thus require alternative treatment, such as cyclophosphamide, cyclosporine, tacrolimus, mycophenolate mofetil, levamisole, or rituximab. To reduce the relapse rate, several drugs have been used. Among these, levamisole has been considered the least toxic and least expensive therapy. Several randomized controlled trials (RCT) showed that levamisole is effective in reducing the relapse risk in steroid sensitive forms of nephrotic syndrome with a low frequency of side effects. Levamisole is a synthetic imidazothiazole derivative with immune-modulatory properties. In this article, we review recent data from randomized trials and observational studies to assess the efficacy of levamisole in frequently relapsing nephrotic syndrome and steroid-dependent nephrotic syndrome. View Full-Text
Keywords: levamisole; nephrotic syndrome; podocyte; steroid-dependent nephrotic syndrome levamisole; nephrotic syndrome; podocyte; steroid-dependent nephrotic syndrome
Show Figures

Figure 1

MDPI and ACS Style

Mühlig, A.K.; Lee, J.Y.; Kemper, M.J.; Kronbichler, A.; Yang, J.W.; Lee, J.M.; Shin, J.I.; Oh, J. Levamisole in Children with Idiopathic Nephrotic Syndrome: Clinical Efficacy and Pathophysiological Aspects. J. Clin. Med. 2019, 8, 860.

Show more citation formats Show less citations formats
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Article Access Map by Country/Region

1
Back to TopTop